Test ID: G6ST
N-Acetylgalactosamine-6-Sulfate Sulfatase, Fibroblasts
Method Description
Describes how the test is performed and provides a method-specific reference
Morquio A disease (MPS IVA) results from a deficiency of the N-acetylgalactosamine-6-sulfate sulfatase enzyme. This enzyme hydrolyzes a sulfate group from the 6 position of galactose at the nonreducing terminus of the mucopolysaccharides, keratin sulfate and chondroitin-6 sulfate.
In this procedure, the tritiated disulfated trisaccharide, (6-DGalNAc-6-SO[4]) 1-4(beta-DGlcU)1-3 (D-[3]H GalNac-ol-6-SO[4]), is used as the substrate. The enzyme hydrolyzes the substrate to form inorganic sulfate and the labeled monosulfated trisaccharide. The monosulfated product is then separated from the disulfated substrate by anion exchange chromatography. The product is then quantitated by scintillation counting. (Glosse J, Kress H: A sensitive procedure for the diagnosis of N-acetylgalatosamine-6-sulfate sulfatase deficiency in classical Morquio's disease. Clin Chim Acta 1978;88:111-119)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Varies


